This registry trial is designed to track the local control rates and side effects of IORT, which will be implemented for women who are suitable partial breast irradiation (PBI) per the latest American Society of Radiation Oncology (ASTRO) guidelines.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of patients with locally controlled disease
Timeframe: 5 years following radiation therapy
Number of patients with regionally controlled disease
Timeframe: 5 years following radiation therapy
Number of patients with grade 2 or higher toxicities
Timeframe: 5 years following radiation therapy